2-methoxyestradiol has been researched along with Barrett Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Banerjee, SK; Dhar, G; Dhar, K; Haque, I; Kambhampati, S; Majumder, M; Mehta, S; Ray, G; Vanveldhuizen, PJ | 1 |
| Banerjee, S; Banerjee, SK; Borrego-Diaz, E; Burns, D; Das, A; Haque, I; Jha, S; Kambhampati, S; Rajewski, RA; Tanol, M; Van Veldhuizen, PJ | 1 |
2 other study(ies) available for 2-methoxyestradiol and Barrett Esophagus
| Article | Year |
|---|---|
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Antineoplastic Agents; Barrett Esophagus; beta Catenin; Cadherins; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Esophageal Neoplasms; Estradiol; Female; Humans; Male; Mice; Mice, Nude; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Estradiol; Humans; Mice; Prodrugs; Xenograft Model Antitumor Assays | 2013 |